S-1/A: Functional Brands Inc. Files Amendment No. 3 to Form S-1 for Initial Public Offering
S-1/A Filing
Functional Brands Inc., formerly HT Naturals Inc., has filed Amendment No. 3 to its Form S-1 registration statement with the SEC for its initial public offering.
Summary
- Functional Brands Inc., formerly HT Naturals Inc., filed Amendment No.
- 3 to its Form S-1 registration statement for an initial public offering.
- The company plans to offer 1,500,000 units, each consisting of one share of common stock, a Series A warrant, and a Series B warrant, at an assumed price of $4.25 per unit.
- The company intends to list its common stock on the Nasdaq under the symbol MEHA.
- The company's products include nutraceutical supplements under the Kirkman brand and hemp-derived products under the HempTown Naturals brand.
- The company intends to use 42% of the net proceeds to cover a deferred payment in connection with the Kirkman acquisition, which has a maturity date of January 1, 2025.
- The company intends to use 6% for marketing awareness, 13% to cover expenses associated with becoming a public company, and 39% for general corporate purposes and working capital.
- The company's net revenue for the nine months ended September 30, 2024, was $4,886,331, compared to $5,268,405 for the nine months ended September 30, 2023.
- The company had a net loss of $275,638 for the nine months ended September 30, 2024, compared to a net loss of $636,897 for the nine months ended September 30, 2023.
- The company's auditor has expressed doubt about its ability to continue as a going concern.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While there are positives such as the established Kirkman brand and growth strategies, the recurring losses, negative cash flows, and auditor's doubt about going concern status raise significant concerns. The dependence on regulatory developments in the hemp industry adds further uncertainty.
Positives
- The company has a 70-year-old Kirkman brand with a loyal consumer base.
- The company maintains high purity and quality standards in the nutraceutical industry.
- The company has launched P2i by Kirkman, a certified prenatal vitamin that aligns with FIGO's position statement.
- The company has an exclusive license agreement with the Trailer Park Boys to market hemp-derived products.
- The company is implementing a growth strategy that includes strengthening the Kirkman brand, launching new brands, modernizing manufacturing capabilities, and investing in sales and marketing.
Negatives
- The company has suffered recurring losses from operations and has a significant accumulated deficit.
- The company continues to experience negative cash flows from operations.
- The company's auditor has expressed doubt about its ability to continue as a going concern.
- The company may be subject to uncertain and evolving federal, state, and local regulations concerning hemp, CBD, and other non-tobacco consumable products.
- The company faces competition from traditional and large, well-financed product manufacturers or distributors.
Risks
- The company may be unable to effectively manage future growth.
- The company will need additional financing in the future, which may not be available when needed or may be costly and dilutive.
- The company has a limited operating history, and it may not be able to successfully operate its business or execute its business plan.
- The company may incur significant debt to finance its operations.
- The company competes in an industry that is brand-conscious, so brand name recognition and acceptance of its products are critical to its success.
- The company's brand and image are keys to its business, and any inability to maintain a positive brand image could have a material adverse effect on its results of operations.
- The company relies on suppliers, manufacturers, and contractors, and events adversely affecting them would adversely affect the company.
- The company has a single customer that accounts for a substantial portion of its revenues, and its business would be harmed were it to lose this customer.
- Wholesale price volatility may adversely affect operations.
- The company may sustain losses that cannot be recovered through insurance or other preventative measures.
- The company may be subject to product liability claims and other claims of its customers and partners.
- If the company encounters product recalls or other product quality issues, its business may suffer.
- It is difficult to predict the timing and amount of the company's sales, and as a result, its sales forecasts are uncertain.
- If the company does not adequately manage its inventory levels, its operating results could be adversely affected.
- Increases in costs or shortages of raw materials could harm the company's business and financial results.
- Increases in costs of energy and increased regulations may have an adverse impact on the company's gross margin.
- Disruption within the company's supply chain, contract manufacturing, or distribution channels could have an adverse effect on its business, financial condition, and results of operations.
- If the company is unable to attract and retain key personnel, its efficiency and operations would be adversely affected; in addition, staff turnover causes uncertainties and could harm its business.
- If the company loses the services of its Chief Executive Officer and/or Chief Financial Officer, its future operations could be impaired until such time as a qualified replacement can be found.
- If the company fails to protect its trademarks and trade secrets, it may be unable to successfully market its products and compete effectively.
- Disruptions to the company's information technology systems due to cyber-attacks or its failure to upgrade and adjust its information technology systems may materially impair its operations, hinder its growth, and materially and adversely affect its business and results of operations.
- The company's business is subject to many regulations, and noncompliance is costly.
- Significant additional labeling or warning requirements may inhibit sales of affected products.
- The company's industry may become subject to expanded regulation and increased enforcement by the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC).
- The company's business and operations would be adversely impacted in the event of a failure or interruption of its information technology infrastructure or as a result of a cybersecurity attack.
- The company's results of operations may fluctuate from quarter to quarter for many reasons, including seasonality.
- Global economic, political, social, and other conditions, including the COVID-19 pandemic, may continue to adversely impact the company's business and results of operations.
- The company may not be able to satisfy listing requirements of NASDAQ or obtain or maintain a listing of its common stock on NASDAQ.
- Prior to this offering, the company was majority-owned by Hemptown Organics Corporation, and a small group of shareholders.
Future Outlook
The company aims to be a leader in the nutraceutical space by manufacturing products held to the highest standard of quality in terms of toxins, metals, and other impurities and plans to do this by strengthening the Kirkman brand, launching multiple brands, modernizing manufacturing capabilities, investing in sales and marketing activities, and identifying key companies for partnerships or acquisitions.
Industry Context
The company operates in the nutraceutical supplement and hemp industries, which are experiencing growth due to increasing health awareness and the legalization of hemp in various countries.
Comparison to Industry Standards
- The global nutritional supplements market is valued at approximately $405.15B in 2023 and is expected to expand at a CAGR of 6.3% from 2023 to 2030, according to Grand View Research.
- The United States nutritional supplements market is valuated at approximately $95.2 billion in 2023 and is expected to expand at a CAGR of 4.8% from 2023 to 2030, according to Grand View Research.
- The United States dietary supplement market is valued at approximately $53.6 billion in 2023 and is expected to expand at a CAGR of 5.7% from 2024 to 2030, according to Grand View Research.
- The global prenatal vitamin supplement market was valued at USD 542.8 million in 2023 and is projected to grow at a CAGR of 8.5% from 2024 to 2030, according to Grand View Research.
- The global CBD consumer health market was valued at USD $19.5B in 2023 and is anticipated to grow at a CAGR of 18.1% during the forecast period, according to Grand View Research.
- The U.S. market value for CBD in 2023 was valued at USD $8.3B, and is expected to grow at a CAGR of 7.6% through 2030, according to Grand View Research.
Legal Proceedings
- True Health Medical Center, S.C. has an ongoing claim against Kirkman Group, Inc., HTO Nevada, Inc., and HTO Holdings, Inc. regarding royalty payments.
Related Party Transactions
- The company has a licensing agreement with Hemptown Organics Corp.
- The company has a licensing agreement with the Trailer Park Boys.
- The company entered into a short-term debt facility with a related party, an officer and director of the parent company Hemptown Organics Corp., whereby the Company received $247,634.
- On March 11, 2024, the Company executed a loan agreement with a related party in the amount of $130,000, with an annual interest rate of 20%, with a maturity date of March 10, 2031.
- We have entered into contractual agreements with our CEO and CFO.
Stakeholder Impact
- Shareholders face a high degree of risk and could lose their investment.
- Employees' job security could be affected by the company's financial performance.
- Customers may be impacted by changes in product availability or quality.
- Suppliers and creditors face the risk of non-payment if the company's financial situation worsens.
Next Steps
- The company intends to apply to list its common stock on the Nasdaq under the symbol MEHA.
- The company plans to use the net proceeds from the offering to grow the company, cover expenses associated with becoming a public company, working capital and general corporate purposes.
Key Dates
| Date | Description |
|---|---|
| November 19, 2020 | Functional Brands Inc. was organized in Delaware. |
| December 10, 2020 | Functional Brands Inc. was granted a licensing agreement by Hemptown Organics Corp. |
| July 21, 2021 | Effective date of the license agreement with the Trailer Park Boys. |
| March 23, 2023 | HT Naturals Inc. changed its name to Functional Brands Inc. |
| May 19, 2023 | HTO Nevada was acquired by Functional Brands through a share exchange agreement. |
| October 2023 | FIGO published a position statement about toxic chemicals and environmental contaminants in prenatal vitamins. |
| April 2024 | Launch of P2i by Kirkman prenatal vitamin. |
| September 24, 2024 | The Company executed a Forbearance Agreement which allows the postponement of principal payment. |
| September 24, 2024 | The Company executed a Confession of Judgement in respect of the principal owed. |
| January 1, 2025 | Maturity date of deferred payment in connection with the Kirkman acquisition. |
| January 8, 2025 | Filing of Registration Statement on Form S-1. |
| January 22, 2025 | The company filed a certificate of amendment of certificate of incorporation with the State of Delaware to immediately effect the Reverse Stock Split. |
| January 24, 2025 | Functional Brands ceased to be deemed a controlled company. |
| February 10, 2025 | Date of Amendment No. 3 to Form S-1. |
Keywords
Functional Brands Inc, initial public offering, IPO, nutraceuticals, supplements, hemp, Kirkman, HempTown Naturals, warrants, NASDAQ, MEHA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.